Envision Healthcare’s Physician Services Business Acquires Alabama Neonatal Medicine, P.C.

NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.–(BUSINESS WIRE)–The Physician Services business of Envision Healthcare Corporation
(NYSE: EVHC) has further expanded its Women’s and Children’s Services
specialty, and its footprint in Alabama, through the acquisition of
Alabama Neonatal Medicine, P.C. The group’s four physicians exclusively
cover the neonatology units at Jackson Hospital, Baptist Medical Center
East and Baptist Medical Center South in the Montgomery, Alabama, area.
This combination provides a complement to Envision’s existing neonatal
programs in Huntsville, Mobile, and Dothan, Alabama.

Dr. Allen Newton, MD, President of Alabama Neonatal Medicine, commented,
“We at Alabama Neonatal Medicine are excited about joining our efforts
with Envision Healthcare. Our focus has always been on improving the
healthcare of infants in central Alabama. Envision not only shares this
goal, but will bring its unparalleled expertise and resources to this
endeavor. Working together with the region’s hospitals and other medical
providers, we will strive to enhance the healthcare experiences and
outcomes of young children and their families throughout central

Robert J. Coward, President of Envision’s Physician Services business,
noted, “We are excited to have been chosen by the physicians of Alabama
Neonatal Medicine as their strategic partner in growing their practice
and providing the necessary resources to thrive in a dynamic healthcare
environment. At Envision, we are committed to the growth and development
of each of our service lines, and this practice is a great addition to
our Women’s and Children’s specialty.”

About Envision Healthcare Corporation

Envision Healthcare Corporation is a leading provider of physician-led
services, ambulatory surgery center management, post-acute care and
medical transportation. Physician-led services encompass providers at
780 hospitals in 45 states and include leadership positions in emergency
department and hospitalist services, anesthesiology, radiology, and
women’s / children’s services, as well as offerings in general surgery
and office-based medicine. As a market leader in ambulatory surgical
care, the company owns and operates 260 surgery centers and one surgical
hospital in 35 states and the District of Columbia, with medical
specialties ranging from gastroenterology to ophthalmology and
orthopedics. Post-acute care is delivered through an array of clinical
professionals and integrated technologies designed to contribute to
efficient and effective population health management strategies. As a
leader in healthcare transportation services, the company operates in 39
states and the District of Columbia. In total, the company offers a
differentiated suite of clinical solutions on a national scale, creating
value for health systems, payors, providers and patients. For additional
information, visit www.evhc.net.

Forward-Looking Statements

Certain statements and information in this communication may be deemed
to be “forward-looking statements” within the meaning of the Federal
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may include, but are not limited to, statements relating to
Envision Healthcare Corporation’s (the “Company”) objectives, plans and
strategies, and all statements (other than statements of historical
facts) that address activities, events or developments that the Company
intends, expects, projects, believes or anticipates will or may occur in
the future. These statements are often characterized by terminology such
as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by the Company’s management in light of their experience and their
perception of historical trends, current conditions, expected future
developments, and other factors they believe to be appropriate. Any
forward-looking statements in this communication are made as of the date
hereof, and the Company undertakes no duty to update or revise any such
statements, whether as a result of new information, future events or
otherwise. Forward-looking statements are not guarantees of future
performance. Whether actual results will conform to expectations and
predictions is subject to known and unknown risks and uncertainties,
including: (i) risks and uncertainties discussed in the reports that
each of the Company, Envision and AMSURG have filed with the Securities
and Exchange Commission; (ii) general economic, market, or business
conditions; (iii) the impact of legislative or regulatory changes, such
as changes to the Patient Protection and Affordable Care Act, as amended
by the Health Care and Education Reconciliation Act of 2010; (iv)
changes in governmental reimbursement programs; (v) decreases in revenue
and profit margin under fee-for-service contracts due to changes in
volume, payor mix and reimbursement rates; (vi) the loss of existing
contracts; (vii) risks associated with the ability to successfully
integrate the Company’s operations and employees following the merger;
(viii) the ability to realize anticipated benefits and synergies of the
business combination; and (ix) the potential impact of the consummation
of the transaction on the Company’s relationships, including with
employees, customers and competitors; and (x) other circumstances beyond
the Company’s control. Refer to the section entitled “Risk Factors” in
each of Envision’s and AMSURG’s annual and quarterly reports filed in
2016 for a discussion of important factors that could cause actual
results, developments and business decisions to differ materially from
forward-looking statements.


Envision Healthcare Corporation
Bob Kneeley, 303-495-1245
President, Investor Relations